These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 27151053)

  • 1. Parkinsonism as a side effect of infliximab.
    Henriksen JN; Eriksson BO
    BMJ Case Rep; 2016 May; 2016():. PubMed ID: 27151053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute Tubulointerstitial Nephritis Associated with Infliximab in a Patient with Crohn's Disease.
    Ota M; Iwai H; Imai K; Kamiya M; Yoshihashi-Nakazato Y; Miyasaka N; Kohsaka H
    Intern Med; 2016; 55(10):1367-70. PubMed ID: 27181549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concomitant Use of Immunomodulators Affects the Durability of Infliximab Therapy in Children With Crohn's Disease.
    Grossi V; Lerer T; Griffiths A; LeLeiko N; Cabrera J; Otley A; Rick J; Mack D; Bousvaros A; Rosh J; Grossman A; Saeed S; Kay M; Boyle B; Oliva-Hemker M; Keljo D; Pfefferkorn M; Faubion W; Kappelman MD; Sudel B; Markowitz J; Hyams JS
    Clin Gastroenterol Hepatol; 2015 Oct; 13(10):1748-56. PubMed ID: 25911120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infliximab-induced seizures in a patient with Crohn's disease: a case report.
    Lv Z; Zhang X; Wu L
    BMC Gastroenterol; 2021 Apr; 21(1):193. PubMed ID: 33906621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Factors for Rescue Therapy in Crohn's Patients Maintained on Infliximab After Withdrawal of the Immunomodulator: A Long-Term Follow-Up.
    Fischer M; Campbell SC; Calley CSJ; Helper DJ; Chiorean MV; Fadda HM
    Dig Dis Sci; 2017 Nov; 62(11):3131-3137. PubMed ID: 28986660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short article: Remicade infusions at home: an alternative setting of infliximab therapy for patients with Crohn's disease.
    Kuin S; Stolte SB; van den Brink GR; Ponsioen CY; Fockens P; D'Haens GR; Löwenberg M
    Eur J Gastroenterol Hepatol; 2016 Feb; 28(2):222-5. PubMed ID: 26566062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Withdrawal of immunomodulators after co-treatment does not reduce trough level of infliximab in patients with Crohn's disease.
    Drobne D; Bossuyt P; Breynaert C; Cattaert T; Vande Casteele N; Compernolle G; Jürgens M; Ferrante M; Ballet V; Wollants WJ; Cleynen I; Van Steen K; Gils A; Rutgeerts P; Vermeire S; Van Assche G
    Clin Gastroenterol Hepatol; 2015 Mar; 13(3):514-521.e4. PubMed ID: 25066841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
    Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infliximab as a bridge to remission maintained by antimetabolite therapy in Crohn's disease: A retrospective study.
    Chauvin A; Le Thuaut A; Belhassan M; Le Baleur Y; Mesli F; Bastuji-Garin S; Delchier JC; Amiot A
    Dig Liver Dis; 2014 Aug; 46(8):695-700. PubMed ID: 24893686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acute appendicitis in a patient with perianal Crohn's disease receiving infliximab].
    Szakács Z; Faluhelyi N; Fincsur A; Papp A; Vincze Á; Bajor J
    Orv Hetil; 2018 Mar; 159(10):405-409. PubMed ID: 29504422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infliximab: an updated review of its use in Crohn's disease and rheumatoid arthritis.
    Keating GM; Perry CM
    BioDrugs; 2002; 16(2):111-48. PubMed ID: 11985485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive central nervous system aspergillosis in a patient with Crohn's disease after treatment with infliximab and corticosteroids.
    Bourne EL; Dimou J
    J Clin Neurosci; 2016 Aug; 30():163-164. PubMed ID: 27050914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pneumocystis jiroveci pneumonia following infliximab therapy in patient with Crohn's disease].
    Fluxá D; Segovia J; Florenzano M; Salinas J; Flores L; Simian D; Quera R
    Rev Chilena Infectol; 2017 Oct; 34(5):518-519. PubMed ID: 29488599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limited granulomatosis with polyangiitis in an adolescent with Crohn's disease on infliximab therapy: cause or coincidence?
    Arora H; Madani S; Debelenko LV; McGrath EJ; Mutyala R; Guglani L
    Clin Respir J; 2015 Oct; 9(4):506-11. PubMed ID: 24865526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short article: Switching to a infliximab biosimilar: short-term results of clinical monitoring in patients with inflammatory bowel disease.
    Binkhorst L; Sobels A; Stuyt R; Westerman EM; West RL
    Eur J Gastroenterol Hepatol; 2018 Jul; 30(7):699-703. PubMed ID: 29538037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing acute infusion reactions in inflammatory bowel disease patients treated with infliximab in the era of scheduled maintenance therapy.
    Duron C; Goutte M; Pereira B; Bommelaer G; Buisson A
    Eur J Gastroenterol Hepatol; 2015 Jun; 27(6):705-11. PubMed ID: 25856689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of continued infliximab therapy in Crohn's disease patients with response but without remission after one year of infliximab - a retrospective cohort study.
    Buhl S; Kristina Borghede M; Brynskov J; Steenholdt C; Rasmussen M; Andrew Ainsworth M
    Scand J Gastroenterol; 2018 Aug; 53(8):930-937. PubMed ID: 29987951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eosinophilic Fasciitis in a Patient With Crohn's Disease Treated With Infliximab. A Rare Coexistence or a Drug-related Manifestation?
    Mpitouli A; Kougkas N; Avgoustidis N; Ergazakis N; Karmiris K
    Inflamm Bowel Dis; 2020 Jul; 26(8):e77-e78. PubMed ID: 32529216
    [No Abstract]   [Full Text] [Related]  

  • 19. A Case of Osteonecrosis of the Jaw in a Patient with Crohn's Disease Treated with Infliximab.
    Favia G; Tempesta A; Limongelli L; Crincoli V; Iannone F; Lapadula G; Maiorano E
    Am J Case Rep; 2017 Dec; 18():1351-1356. PubMed ID: 29257800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Retrospective Claims Database Study on Drug Utilization in Japanese Patients with Crohn's Disease Treated with Adalimumab or Infliximab.
    Yokoyama K; Yamazaki K; Katafuchi M; Ferchichi S
    Adv Ther; 2016 Nov; 33(11):1947-1963. PubMed ID: 27664107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.